↓ Skip to main content

Dimethyl Fumarate Combined With Vemurafenib Enhances Anti-Melanoma Efficacy via Inhibiting the Hippo/YAP, NRF2-ARE, and AKT/mTOR/ERK Pathways in A375 Melanoma Cells

Overview of attention for article published in Frontiers in oncology, January 2022
Altmetric Badge

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
14 Mendeley